Journal of Obstetrics, Gynecology and Cancer Research

Published by: Kowsar

Human Papillomavirus Vaccination: Is it Cost-Effective in Iran?

Authors Information
1 Department of Health Economics and Management Sciences, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
2 Gheam Hospital, Women Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 Resident of Obstetric and Gynecology
4 Tehran University of Medical Sciences, Tehran, Iran
Article Notes and Dates
Journal of Obstetrics, Gynecology and Cancer Research: February 2017, 2 (1); e10218.Published Online: February 26, 2017
Article Type: Letter; Received : December 27, 2016; Accepted : March 1, 2017

To Cite : Yousefi M, Hasanzadeh M, Rostaminezhad V, Gaffarean M, Mousavi A S. et al. Human Papillomavirus Vaccination: Is it Cost-Effective in Iran?, J Obstet Gynecol Cancer Res. 2017 ;2(1):e10218. doi: 10.5812/jogcr.10218.

Copyright: Copyright © 2017, Journal of Obstetrics, Gynecology and Cancer Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Khatibi M, Rasekh HR, Shahverdi Z, Jamshidi HR. Cost-effectiveness evaluation of quadrivalent human papilloma virus vaccine for HPV-related disease in Iran. Iran J Pharm Res. 2014; 13: 225-34[PubMed]
  • 2. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63: 1-30[PubMed]
  • 3. Iarc Working Group on the Evaluation of Carcinogenic Risks to Humans . Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012; 100: 1-441[PubMed]
  • 4. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11): 1048-56[DOI][PubMed]
  • 5. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006; 24 Suppl 3-41[DOI][PubMed]
  • 6. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec. 2014; 89(43): 465-91[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Search Relations:



Create Citiaion Alert via Google Reader